ReachMD

CME

Não deixe de visitar o site do podcast e apoiar quem o produz: reachmd.com

Autor

ReachMD

Categoria

Science

Site do podcast

reachmd.com

Último episódio

26 de out de 2026

Onde ouvir?

Podcasts no app Replaio Radio Em breve

Os podcasts estão chegando ao app. Instale agora e seja o primeiro a descobrir um jeito totalmente novo de curtir podcasts

Baixe no Google Play Instale grátis Android 10 mi+ downloads · nota 4,7+ iOS em breve

Episódios

The Treatment Planning Process for Atopic Dermatitis 26.10.2026

Guest: Brad Glick, DO, MPH Brad P. Glick, DO, MPH, FAAD, explains the importance of developing a written treatment plan for managing atopic dermatitis and its associated comorbidities.

A Multidisciplinary Approach to Treating Itch 23.10.2026

Guest: J. Mark Jackson, MD Mark Jackson, MD, addresses the various factors contributing to itch and how a multidisciplinary treatment approach can help.

The Binder Selection Playbook: Matching the Right Strategy to the Right Patient 20.10.2026

Faculty: James Burton, DM, FRCP Faculty: Nihar R. Desai, MD, MPH This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while maintaini...

From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection 20.10.2026

Faculty: James Burton, DM, FRCP Faculty: Pauline A. Swift, PhD This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while maintaining...

CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia 20.10.2026

Faculty: Ellie Kelepouris, MD, FACP, FAHA Faculty: Pauline A. Swift, PhD This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while m...

Potassium Binders to Optimize GDMT Therapy in HFrEF 20.10.2026

Faculty: Nihar R. Desai, MD, MPH Faculty: Ellie Kelepouris, MD, FACP, FAHA This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while...

The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion 20.10.2026

Faculty: Nihar R. Desai, MD, MPH Faculty: Pauline A. Swift, PhD This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while maintainin...

Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load 20.10.2026

Faculty: James Burton, DM, FRCP Faculty: Ellie Kelepouris, MD, FACP, FAHA This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while...

Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex 20.10.2026

Faculty: James Burton, DM, FRCP Faculty: Nihar R. Desai, MD, MPH This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while maintaini...

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs 20.10.2026

Faculty: Ellie Kelepouris, MD, FACP, FAHA This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based discussions, faculty review guideline-based strategies for managing hyperkalemia while maintaining or optimizing renin-...

From Evidence to Action: Advancing Care in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome 08.10.2026

Faculty: Dr. Ioanna Gouni-Berthold, MD Faculty: Gerald Watts, MD, PhD How should emerging APOC3-targeted therapies change the conversation around severe hypertriglyceridemia (sHTG) and familial chylomicronemia syndrome (FCS)? Drs. Gerald Watts and Ioanna Gouni-Berthold examine findings from SHASTA-3, SHASTA-4, CORE, CORE2, PALISADE, and BALANCE, with a focus on triglyceride lowering, acute pancrea...

Potential Impact of Aryl Hydrocarbon Activation on Pigment 08.10.2026

Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the sixth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, speculate about normalization of pigment as a potential benefit of aryl hydrocarbon receptor agonism.

Managing Patient Expectations with Topical Therapies 08.10.2026

Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the fifth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, talk about the challenges involved with setting treatment goals with inflammatory dermatoses.

Various Benefits of Aryl Hydrocarbon Receptor Agonists 08.10.2026

Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the fourth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, discuss how topical therapies can be used to control inflammation and how to talk about that with patients.

Skin Barrier Maintenance in Atopic Dermatitis and Psoriasis 08.10.2026

Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the third installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, describe the importance of skin barrier maintenance in treating inflammatory dermatoses.

Tapinarof’s Place in Inflammatory Disease Treatment 08.10.2026

Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the second installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, explain how tapinarof fits in the armamentarium for treating inflammatory dermatoses.

Mechanism of Action for Aryl Hydrocarbon Receptor Agonists 08.10.2026

Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the first installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, discuss the aryl hydrocarbon receptor (AhR) pathway and how AhR agonists work.

When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease 23.09.2026

Faculty: Dani Cabral, MD Faculty: David Weisman, MD As anti-amyloid therapies reshape the management of early symptomatic Alzheimer’s disease, timely recognition, accurate diagnosis, and appropriate patient selection are increasingly important in clinical practice. In this expert-led series, Dr. David Weisman and Dr. Dani Cabral explore practical approaches to identifying patients with mild cognit...

Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum 18.09.2026

Faculty: Jose M. Rubio, MD, PhD Faculty: Sunny X. Tang, MD In this MinuteCE, Drs. Jose Rubio and Sunny Tang examine the recurrent course of bipolar disorder, predictors of relapse, and the clinical burden of residual mood symptoms and cognitive impairment. They discuss limitations of current pharmacologic therapies and review dopaminergic and cholinergic neurocircuitry, with emphasis on M1 and M4...

The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder 18.09.2026

Faculty: Jose M. Rubio, MD, PhD Faculty: Sunny X. Tang, MD In this MinuteCE, Drs. Jose Rubio and Sunny Tang examine the recurrent course of bipolar disorder, predictors of relapse, and the clinical burden of residual mood symptoms and cognitive impairment. They discuss limitations of current pharmacologic therapies and review dopaminergic and cholinergic neurocircuitry, with emphasis on M1 and M4...

Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity 18.09.2026

Faculty: Jose M. Rubio, MD, PhD Faculty: Sunny X. Tang, MD In this MinuteCE, Drs. Jose Rubio and Sunny Tang examine the recurrent course of bipolar disorder, predictors of relapse, and the clinical burden of residual mood symptoms and cognitive impairment. They discuss limitations of current pharmacologic therapies and review dopaminergic and cholinergic neurocircuitry, with emphasis on M1 and M4...

Navigating the Limitations of Current BD Therapies 18.09.2026

Faculty: Jose M. Rubio, MD, PhD Faculty: Sunny X. Tang, MD In this MinuteCE, Drs. Jose Rubio and Sunny Tang examine the recurrent course of bipolar disorder, predictors of relapse, and the clinical burden of residual mood symptoms and cognitive impairment. They discuss limitations of current pharmacologic therapies and review dopaminergic and cholinergic neurocircuitry, with emphasis on M1 and M4...

Recurrence as the Rule: BD Symptoms Persist and Cycle 18.09.2026

Faculty: Jose M. Rubio, MD, PhD Faculty: Sunny X. Tang, MD In this MinuteCE, Drs. Jose Rubio and Sunny Tang examine the recurrent course of bipolar disorder, predictors of relapse, and the clinical burden of residual mood symptoms and cognitive impairment. They discuss limitations of current pharmacologic therapies and review dopaminergic and cholinergic neurocircuitry, with emphasis on M1 and M4...

The Future of IgAN Care 31.08.2026

Faculty: Chee Kay Cheung, MBChB, MRCP, PhD Faculty: An De Vriese, MD, PhD Faculty: Jörg Latus, MD This comprehensive educational activity focuses on 4 key dimensions of IgA nephropathy (IgAN) management. First, attendees will compare and contrast the mechanisms of action (MOAs) of both approved and investigational IgAN therapies, critically evaluating how each targets specific disease pathways—suc...

The Evolving Role of Biomarkers in IgAN 31.08.2026

Faculty: Chee Kay Cheung, MBChB, MRCP, PhD This comprehensive educational activity focuses on 4 key dimensions of IgA nephropathy (IgAN) management. First, attendees will compare and contrast the mechanisms of action (MOAs) of both approved and investigational IgAN therapies, critically evaluating how each targets specific disease pathways—such as galactose-deficient IgA1 formation, complement act...

Ouça o podcast CME no Replaio

Rádio e podcasts em um só app - grátis e sem cadastro. Instale hoje e não perca o lançamento

Baixe no Google Play

O Replaio não é o publicador dos podcasts; os nomes dos programas, as capas e o áudio pertencem aos seus autores e são distribuídos por feeds RSS públicos